𝕏
Latest

Author

Clara Ashworth

Deals and business correspondent

Clara Ashworth covers biopharma mergers, acquisitions, licensing deals and corporate strategy for PharmaWire, from big-pharma takeovers to early-stage China out-licensing.

Latest from Clara Ashworth